Mary Spellman
Company: Clexio Biosciences
Job title: Medical Advisor
Seminars:
Introducing CLE-400; Topical Alpha-2- Adrenergic Agonist as a First-in- Class Treatment for Localized Chronic Pruritus 1:30 pm
Exploring activation of α2 adrenergic receptors on skin nociceptors in attenuating neural itch signaling Detailing the effects of CLE-400 in preclinical pharmacological models Presenting Notalgia Ptaresthetica as the first indication for CLE 400’s clinical developmentRead more
day: Conference Day Two